Genomic alterations in primary cutaneous melanomas detected by metaphase comparative genomic hybridization with laser capture or manual microdissection: 6p Gains may predict poor outcome

Cancer Genetics and Cytogenetics

Volumn 157, Issue 1, 2005, Pages 1-11

  Namiki, Takeshi ^a,d   Yanagawa, Shigeru ^a   Izumo, Toshiyuki ^a   Ishikawa, Masashi ^a   Tachibana, Masayoshi ^b   Kawakami, Yutaka ^c   Yokozeki, Hiroo ^d   Nishioka, Kiyoshi ^d   Kaneko, Yasuhiko ^a  

^a SAITAMA CANCER CENTER   (Japan)

^b NIIGATA UNIVERSITY   (Japan)

^c KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; CANCER CELL CULTURE; CANCER CLASSIFICATION; CANCER PATIENT; CANCER SURVIVAL; CHROMOSOME 10P; CHROMOSOME 10Q; CHROMOSOME 11Q; CHROMOSOME 1Q; CHROMOSOME 20P; CHROMOSOME 20Q; CHROMOSOME 2Q; CHROMOSOME 3P; CHROMOSOME 3Q; CHROMOSOME 5Q; CHROMOSOME 6P; CHROMOSOME 6Q; CHROMOSOME 7Q; CHROMOSOME 9P; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; CHROMOSOME MICRODISSECTION; CLINICAL FEATURE; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GENE MUTATION; GENOMICS; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; LASER CAPTURE MICRODISSECTION; MALE; MEASUREMENT; MELANOMA; MELANOMA CELL; METAPHASE COMPARATIVE GENOMIC HYBRIDIZATION; OUTCOMES RESEARCH; PREDICTION; PRIORITY JOURNAL; REVIEW; THICKNESS; TUMOR;

EID: 12844264129     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2004.06.004     Document Type: Article

References (21)

1. C.L. Day, M.C. Mihm, A.J. Sober, M.N. Harris, A.W. Kopf, T.B. Fitzpatrick, R.A. Lew, T.J. Harrist, F.M. Golomb, A. Postel, P. Hennessey, S.L. Gumport, J.W. Raker, R.A. Malt, A.B. Cosimi, W.C. Wood, D.F. Roses, F. Gorstein, D. Rigel, R.J. Friedman, and M.M. Mintzis Prognostic factors for melanoma patients with lesions 0.76-1.69 mm in thickness: an appraisal of thin level IV lesions Ann Surg 195 1982 30 34
2. C.M. Balch, S.J. Soong, J.E. Gershenwald, J.F. Thompson, D.S. Reintgen, N. Cascinelli, M. Urist, K.M. McMaster, M.I. Ross, J.M. Kirkwood, M.B. Atkins, J.A. Thompson, D.G. Coit, D. Byrd, R. Desmond, Y. Zhang, P.Y. Liu, G.H. Lyman, and A. Morabito Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on cancer melanoma staging system J Clin Oncol 19 2001 3622 3634
3. F.H. Thompson, J. Emerson, S. Olson, R. Weinstein, S.A. Leavitt, S.P.L. Leong, S. Emerson, J.M. Trent, M.A. Nelson, S.E. Salmon, and R. Taetle Cytogenetics of 158 patients with regional or disseminated melanoma Cancer Genet Cytogenet 83 1995 93 104
4. B.C. Bastian, P.E. LeBoit, H. Hamm, E.B. Brocker, and D. Pinkel Chromosomal gains and losses in primary cutaneous melanomas detected by comparative genomic hybridization Cancer Res 58 1998 2170 2175
5. B.C. Bastian, M. Kashani-Sabet, H. Hamm, H. Hamm, T. Godfrey, D.H. Moore II, E.B. Brocker, P.E. LeBoit, and D. Pinkel Gene amplifications characterize acral melanoma and permit the detection of occult tumor cells in the surrounding skin Cancer Res 60 2000 1968 1973
6. B.C. Bastian, A.B. Olshen, P.E. LeBoit, and D. Pinkel Classifying melanocytic tumors based on DNA copy number changes Am J Pathol 163 2003 1765 1770
7. J.M. Trent, F.L. Meyskens, S.E. Salmon, K. Ryschon, S.P. Leong, J.R. Davis, and D.L. McGee Relation of cytogenetic abnormalities and clinical outcome in metastatic melanoma N Engl J Med 322 1990 1508 1511
8. W.H. Clark Jr., D.E. Elder, and M. Van Horn The biologic forms of malignant melanoma Hum Pathol 17 1986 443 450
9. C.M. Balch, A.C. Buzaid, S.J. Soong, M.B. Atkins, N. Cascinelli, D.G. Coit, I.D. Fleming, J.E. Gershenwald, A. Houghton, J.M. Kirkwood, K.M. McMaster, M.F. Mihm, D.L. Morton, D.S. Reintgen, M.I. Ross, A. Sober, J.A. Thompson, and J.F. Thompson Final version of the American Joint Committee on cancer staging system for cutaneous melanoma J Clin Oncol 19 2001 3635 3648
10. J. Isola, S. DeVries, L. Chu, S. Ghazvini, and F. Waldman Analysis of changes in DNA sequence copy number by comparative genomic hybridization in archival paraffin-embedded tumor samples Am J Pathol 145 1994 1301 1308
11. Q. Huang, S.P. Schantz, P.H. Rao, J. Mo, S.A. McCormick, and R.S.K. Chaganti Improving degenerate oligonucleotide primed PCR-comparative genomic hybridization for analysis of DNA copy number changes in tumors Genes Chromosomes Cancer 28 2000 395 403
12. K. Kumon, H. Kobayashi, T. Namiki, Y. Tsunematsu, J. Miyauchi, A. Kikuta, Y. Horikoshi, Y. Komada, Y. Hatae, H. Eguchi, and Y. Kaneko Frequent increase of DNA copy number in the 2q24 chromosomal region and its association with a poor clinical outcome in hepatoblastoma: cytogenetic and comparative genomic hybridization analysis Jpn J Cancer Res 92 2001 854 862
13. S. Manolidis, and P.J. Donald Malignant mucosal melanoma of the head and neck: review of the literature and report of 14 patients Cancer 80 1997 1373 1386
14. M.V. Dijk, S. Sprenger, P. Rombout, H. Marres, J. Kaanders, J. Jeuken, and D. Ruiter Distinct chromosomal aberrations in sinonasal mucosal melanoma as detected by comparative genomic hybridization Genes Chromosomes Cancer 36 2003 151 158
15. J. Richter, U. Wagner, P. Schraml, R. Maurer, G. Alund, H. Knonagel, H. Moch, M.J. Mihatsch, T.C. Gasser, and G. Sauter Chromosomal imbalances are associated with a high risk of progression in early invasive (pT1) urinary bladder cancer Cancer Res 59 1999 5687 5691
16. D. Chen, B.L. Gallie, and J.A. Squire Minimal regions of chromosomal imbalance in retinoblastoma detected by comparative genomic hybridization Cancer Genet Cytogenet 129 2001 57 63
17. J.A. Veltman, J. Fridlyand, P. Pejavar, A.B. Olshen, J.E. Korkola, S. DeVries, P. Carroll, W.L. Kuo, D. Pinkel, D. Albertson, C.C. Cardo, A.N. Jain, and F.M. Waldman Array-based comparative genomic hybridization for genome-wide screening of DNA copy number in bladder tumors Cancer Res 63 2003 2872 2880
18. G.K. Fu, G. Grosveld, and D.M. Markovitz DEK, an autoantigen involved in a chromosomal translocation in acute myelogenous leukemia, binds to the HIV-2 enhancer Proc Natl Acad Sci USA 94 1997 1811 1815
19. L. Wu, C. Timmers, B. Maiti, H.I. Saavedra, L. Sang, G.T. Chong, F. Nuckolls, P. Giangrande, F.A. Wright, S.J. Field, M.E. Greenberg, S. Orkin, J.R. Nevins, M.L. Robinson, and G. Leone The E2F1-3 transcription factors are essential for cellular proliferation Nature 414 2001 457 462
20. R. Halaban, E. Cheng, Y. Smicun, and J. Germino Deregulated E2F transcriptional activity in autonomously growing melanoma cells J Exp Med 191 2000 1005 1015
21. J.M. Trent, F.H. Thompson, and F.L. Meyskens Identification of a recurring translocation site involving chromosome 6 in human malignant melanoma Cancer Res 49 1989 420 423